Education
About Us
Working with TipRanks
Follow Us
Noubar Afeyan Insider Profile
18 Followers
Noubar Afeyan, Director, Ten Percent Owner at BG Medicine, holds 6.86M shares in Moderna (Ticker: MRNA), holds 17.14M shares in Seres Therapeutics (Ticker: MCRB), holds 1.29M shares in BG Medicine (Ticker: BGMD). Most recently, Noubar Afeyan Sold ― shares of Moderna on Dec 15, 2025 for an estimated value of $703.19K.
Noubar Afeyan BG Medicine (BGMD)Director, Ten Percent Owner
BG Medicine (BGMD)
Director, Ten Percent Owner
Ranked #5,936 out of 105,518 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+52.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Noubar Afeyan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Noubar Afeyan
Noubar Afeyan's Trading History
BG Medicine
Dec 11, 2015
Director, Ten Percent Owner
Informative Sell
26.01K
―
Seres Therapeutics
Jun 20, 2019
Director, Ten Percent Owner
Informative Buy
20.00M
$255.77M
Moderna
Dec 15, 2025
Director
Informative Sell
703.19K
$302.15M
Rubius Therapeutics
―
―
―
―
Evelo Biosciences
―
Director, Ten Percent Owner
―
―
Omega Therapeutics
―
―
―
―
DNIB Unwind, Inc.
Sep 27, 2013
―
Uninformative Buy
―
$226.58K
Agenus
―
Director
―
$0.00
Carisma Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Noubar Afeyan's performance on stock
You May Also Like
Noubar Afeyan insider profile FAQ
What is the percentage of profitable transactions made by Noubar Afeyan?
The percentage of profitable transactions made by Noubar Afeyan is 83%.
What is the average return per transaction made by Noubar Afeyan?
The average return per transaction made by Noubar Afeyan is 52.30%.
What stocks does Noubar Afeyan hold?
Noubar Afeyan holds: BGMD, MCRB, MRNA, RUBY, EVLO, OMGAQ, BINDQ, AGEN, CARM stocks.
What was Noubar Afeyan’s latest transaction?
Noubar Afeyan latest transaction was an Informative Sell of $703.19K.
What was Noubar Afeyan's most profitable transaction?
Noubar Afeyan’s most profitable transaction was an Informative Sell of BGMD stock on December 11, 2015. The return on the trade was 91.90%.
What is Noubar Afeyan's role in BG Medicine?
Noubar Afeyan's role in BG Medicine is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.